Internal Medicine, Medical Oncology · Pasadena, CA
NPI
1013957190
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1121 Arden Rd
Pasadena, CA, 91106
Phone (626) 256-4673
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.8M
1,296 prescriptions
Company payments, 2024
$105
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Gargi H Upadhyaya prescribed most often to Medicare patients was Anastrozole, with 115 prescriptions and refills. In total Gargi H Upadhyaya wrote 1,296 Medicare prescriptions that cost $3.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 115 | 340 | 35 | $2,328 |
| Lupron Depot Leuprolide Acetate | 72 | 104 | 13 | $188K |
| Procrit Epoetin Alfa | 60 | 60 | 11 | $80K |
| Diphenhydramine Hcl Generic | 48 | 54 | 13 | $88.88 |
| Ondansetron Hcl Ondansetron Hcl/Pf | 47 | 47 | 11 | $84.25 |
| Dexamethasone Sodium Phosphate Generic | 46 | 46 | 11 | $91.47 |
| Eliquis Apixaban | 42 | 52 | Under 11 | $28K |
| Dexamethasone Generic | 41 | 41 | Under 11 | $617 |
| Famotidine Famotidine/Pf | 38 | 38 | Under 11 | $50.49 |
| Zoledronic Acid Zoledronic Ac/Mannitol/0.9nacl | 36 | 72 | Under 11 | $4,133 |
| Lorazepam Generic | 28 | 28 | 13 | $110 |
| Ondansetron Hcl Generic | 27 | 27 | 12 | $266 |
| Prochlorperazine Maleate Generic | 24 | 24 | 11 | $308 |
| Opdivo Nivolumab | 24 | 24 | Under 11 | $219K |
| Rituxan Rituximab | 24 | 24 | Under 11 | $79K |
Brand drugs: 573 claims; generic drugs: 723 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Gargi H Upadhyaya $105 ($105 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $68.08.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.